How is the Heng Criteria Applied to Kidney Cancer Patients?

GRACEcast by Howard (Jack) West, MD

Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.

Related Episodes

Continue listening to more episodes from GRACEcast.

Jul 31, 2014 - 04:36

Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung canc...

Jul 29, 2014 - 01:55

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for...

Jul 27, 2014 - 05:28

The doctors discuss the circumstances under which small cell lung cancer patients should receive prophyla...

Jul 24, 2014 - 02:03

NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and,...

Jul 22, 2014 - 02:27

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lu...

Jul 17, 2014 - 07:28

The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab...

Jul 15, 2014 - 03:15

Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and h...

Jul 13, 2014 - 07:22

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib),...